Epigallocatechin-3-Gallate (EGCG) Suppresses Pancreatic Cancer Cell Growth, Invasion, and Migration partly through the Inhibition of Akt Pathway and Epithelial–Mesenchymal Transition: Enhanced Efficacy when Combined with Gemcitabine

Phase I/II Trial to Evaluate the Efficacy and Safety of Nanoparticle Albumin-Bound Paclitaxel in Combination With Gemcitabine in Patients With Pancreatic Cancer and an ECOG Performance Status of 2

(2018) Teresa Macarulla et al.   JOURNAL OF CLINICAL ONCOLOGY

Molecular Targets of Epigallocatechin—Gallate (EGCG): A Special Focus on Signal Transduction and Cancer

(2018) Aide Negri et al.   Nutrients

A systematic assessment of statistics, risk factors, and underlying features involved in pancreatic cancer

(2018) Imlimaong Aier et al.   Cancer Epidemiology

A central role for cadherin signaling in cancer

(2017) Antonis Kourtidis et al.   EXPERIMENTAL CELL RESEARCH

Epigallocatechin-3-gallate, a prototypic chemopreventative agent for protection against cisplatin-based ototoxicity

(2017) Vikrant Borse et al.   Cell Death & Disease

(−)-Epigallocatechin-3-Gallate Inhibits Colorectal Cancer Stem Cells by Suppressing Wnt/β-Catenin Pathway

(2017) Yue Chen et al.   Nutrients

Down-regulation of C35 decreased the cell viability and migration of breast ductal carcinoma cells

(2017) Wen Che et al.   PLoS One

The novel agent phospho-glycerol-ibuprofen-amide (MDC-330) inhibits glioblastoma growth in mice: an effect mediated by cyclin D1

(2016) Lauren E. Bartels et al.   CARCINOGENESIS

Epigallocatechin Gallate Nanodelivery Systems for Cancer Therapy

(2016) Andreia Granja et al.   Nutrients

EGCG Inhibits Proliferation, Invasiveness and Tumor Growth by Up-Regulation of Adhesion Molecules, Suppression of Gelatinases Activity, and Induction of Apoptosis in Nasopharyngeal Carcinoma Cells

(2015) Chih-Yeu Fang et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

A new role for the PI3K/Akt signaling pathway in the epithelial-mesenchymal transition

(2015) Wenting Xu et al.   Cell Adhesion & Migration

Targeting mTOR dependency in pancreatic cancer

(2014) Douglas C Morran et al.   GUT

Biochemical and Cellular Evidence Demonstrating AKT-1 as a Binding Partner for Resveratrol Targeting Protein NQO2

(2014) Tze-chen Hsieh et al.   PLoS One

Targeting Mitochondrial STAT3 with the Novel Phospho-Valproic Acid (MDC-1112) Inhibits Pancreatic Cancer Growth in Mice

(2013) Gerardo G. Mackenzie et al.   PLoS One

EGCG Enhances the Therapeutic Potential of Gemcitabine and CP690550 by Inhibiting STAT3 Signaling Pathway in Human Pancreatic Cancer

(2012) Su-Ni Tang et al.   PLoS One

Phospho-Sulindac (OXT-328) Combined with Difluoromethylornithine Prevents Colon Cancer in Mice

(2011) Gerardo G. Mackenzie et al.   Cancer Prevention Research

Metastasis and AKT activation

(2011) Meng Qiao et al.   CELL CYCLE

A Perspective on Cancer Cell Metastasis

(2011) C. L. Chaffer et al.   SCIENCE

Biomarkers for epithelial-mesenchymal transitions

(2009) Michael Zeisberg et al.   JOURNAL OF CLINICAL INVESTIGATION

Curcumin induces cell-arrest and apoptosis in association with the inhibition of constitutively active NF-κB and STAT3 pathways in Hodgkin's lymphoma cells

(2008) Gerardo G. Mackenzie et al.   INTERNATIONAL JOURNAL OF CANCER